Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,354.00
Ask: 12,358.00
Change: 166.00 (1.36%)
Spread: 4.00 (0.032%)
Open: 12,304.00
High: 12,378.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Markets Buoyed By US Stimulus Progress

Mon, 08th Feb 2021 07:02

(Alliance News) - Stock prices in London are seen opening higher at the start of the week, with the mood in global markets lifted by hopes for a new US stimulus package.

US President Joe Biden seized on feeble US employment data, published on Friday, to argue the world's largest economy needs his USD1.9 trillion pandemic relief package, which cleared a key Senate hurdle without support from the Republican opposition.

"I believe the American people are looking right now to their government for help," Biden said after a meeting with top Democratic lawmakers. "So I'm going to act. I'm going to act fast."

IG futures indicate the FTSE 100 index is to open 40.2 points higher at 6,529.53 on Monday. The blue-chip index closed down 0.2%, or 14.39 points at 6,489.33 on Friday.

"At the back end of last week, the Biden administration put in motion a plan to get the USD1.9 trillion stimulus package signed off without support from Republican lawmakers. President Biden has a history of fostering good relations with politicians from across the aisle as well as seeking consensus on issues but this time he is determined to put the American people first," CMC Markets analyst David Madden said.

"The stimulus move also helped US equities notch up a record close. Janet Yellen, the US treasury secretary, claimed the US economy could return to full employment next year if President Biden's USD1.9 trillion relief package is passed. The positive sentiment from the US at the end of last week helped Asian equity markets. European stock markets are on track for a positive start."

On Friday, the Dow Jones Industrial Average closed up 0.3%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.6%.

The Japanese Nikkei 225 index jumped 2.2% on Monday, closing above the 29,000 mark. In China, the Shanghai Composite was 0.9% higher in late trade, while the Hang Seng index in Hong Kong is up 0.3%.

"Chinese has released anti-monopoly news today, aimed squarely at China big-tech companies. Markets seem to have priced this in for now though, with mainland markets slightly higher and large Hong Kong-listed China technology companies outperforming there this morning," OANDA Asia Pacific Senior Market Analyst Jeffrey Halley said.

Tencent Holdings shares were 1.0% higher in Hong Kong.

In Sydney, the ASX 200 closed up 0.6%.

Sterling was trading at USD1.3726 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

CMC's Madden added: "The UK continues to be one of the best countries in the world as far as the vaccination rollout is concerned, approximately 17% of the population have received their first jab of the vaccine. It is not all good news on the health front though, the AstraZeneca-Oxford vaccine is not effective against the South African strain of the coronavirus."

South Africa has temporarily suspended the AstraZeneca and Oxford University jab against a new variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

The euro stood at USD1.2033 on Monday morning London time, up from USD1.2025 at the European equities close on Friday. Against the yen, the dollar was trading at JPY105.51, improved from JPY105.45 at the same time Friday.

Brent oil was quoted at USD59.76 a barrel, up from USD59.62 a barrel at the London equities close Friday. Gold fetched USD1,815.23 an ounce, up from USD1,808.40.

A quiet economic calendar on Monday has German industrial production figures at 0700 GMT.

The UK corporate calendar on Monday has full-year results from property manager Inland Homes and trading statements from industrial and electronic products distributor Electrocomponents and consumer goods brand designer UP Global Sourcing Holdings.

Later in the week, the US earnings season picks up pace again, with social networking site Twitter reporting on Tuesday, soft drinks heavyweight Coca-Cola on Wednesday, and Walt Disney on Thursday.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.